Skip to content
World Hub Media

Zimbabwe Declines ‘Unbalanced’ American Healthcare Assistance Package Because of Data Fears

Medical aid image
The offered US financial assistance was aimed at initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has declined a significant US health deal worth 367 million US dollars (£272m) spanning five years due to the United States' demand for confidential data.

This move was revealed after a government memo from December was leaked, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "unbalanced".

A government spokesman later stated that the United States was seeking genetic material for research and commercial purposes while was not willing to guarantee the resulting advantages from any future vaccines.

"We will now turn to the challenging and unfortunate task of ending our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy noted the US had provided over $1.9bn as health assistance to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has appealed for continued talks to find a agreement agreeable to all parties so the nation's vital HIV programme can be sustained.

Wider Background

Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a high court suspended a related deal with the US after concerns were filed about the safety of citizens' health data.

After returning to office last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).

The agency had administered aid for the American government, but Trump argued its spending was "inefficient" and his government was pursuing government-to-government agreements to enhance transparency and accountability.

According to reports, 16 nations in Africa have to date signed similar health pacts, constituting more than $18.3bn in committed funds.

Details of the Declined Agreement

This assistance for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this cooperation could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy via American-funded initiatives," the Ambassador commented.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".

"Our nation was requested to surrender its genetic material and health information over an extended period, with no equivalent guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that might result from that shared data," his statement read.

"In essence, our nation would provide the basic resources for scientific discovery without any certainty that the resulting innovations would be available to our population if a future disease outbreak arise."

National Interest and Global Health

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting structures already set up through the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage potential global health emergencies.

"This mechanism is intended to guarantee that when a country provides its samples, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised solely by those with the resources to create them."

These objections regarding the US deal "must not be interpreted as hostility towards the US," he added.

"We are open to further discussions with our US partners on how future co-operation might be arranged in a way that honours the independence and interests of each country."

Health Experts Reaction

Medical experts stated it recognised the government's concerns, but recommended that talks need to persist given that a large portion of the nation's Aids initiatives relied on foreign aid.

"Where specific concerns arise, including those involving information security or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," it added.

The halted deal emphasises the ongoing debate between receiving crucial international aid and protecting local interests in an increasingly data-driven world.

The writer

Kevin Dunn

Elara Vance is a seasoned journalist specializing in international affairs and digital media trends, with over a decade of experience reporting from across the globe.

World Hub Media

Type to search articles.